Sudhichai Chokekijchai, M.D., FRCP (Thai).
15th, 1960

Nationality: Thai

Marital Status: Single

1990: Fellow of Thai Royal College of Physician, Bangkok
Hospital, Mahidol University, Bangkok
1984: B.Sc , Mahidol University, Bangkok


Thai, English


17/258 Prachachuen Rd., Tungsonghong, Laksri, Bangkok 1210, Thailand

Current Professional Affiliation:

Member of Thai Royal college of Physician
Member of Thai Allergy and Immunology Association
Member of Thai Infectious Diseases Association

Career history:
1987-1998 Government
Chief Resident, Internal Medicine
Staff of Allergy and Immunology Unit
• National Cancer Institute ( 1995-1996), USA General fellowship (Research in HIV drug)
Staff of Allergy and Immunology Unit
Sep 1997 to Sep 1998
Bangkok, Thailand
Medical Director
Sep 1998 to Dec 2000
Eli-Lilly Asia Inc. Thailand Branch
Bangkok, Thailand
Medical Director
Jan 2001 to Aug 2008
AstraZeneca (Thailand) Ltd.
Medical director
Sep 2008 to present
Novartis (Thailand) Ltd.
Chief Scientific Officer
1) Xu ZQ, Qiu Y-L Chokekijchai S, Mitsuya H, Zemlicka J. Unsaturated Acyclic Analogues of 2’- Deoxyadenosine and Thymidine Containing Fluoride: synthesis and Biological Activity. Journal
of Med. Chem
. 1995, 38: 875-882
2) Shirasaka T, Kavlick MK, Ueno T, Gao W-Y, Kojima E, Alcide ML, Chokekijchai S, Roy BM, Arnold E, Yarchoan R, Mitsuya H. Emergence of Human immunodeficiency Virus Type I Variants
with Resistance to Multiple Dideoxynucleosides in Patients Receiving Therapy with
. PNAS 1995, 92: 2398-2402
3) Kojima E, Shirasaka T, Anderson BD, Chokekijchai S, Steinberg SM, Broder S, Yarchoan R, Mitsuya H. Human Immunodeficeincy Virus type I (HIV-1) Viremia changes and Development of
Drug-Related Mutations in Patients with Symptomatic HIV infection Receiving Alternating or
Simultaneous Zidovudine and Didanosine Therapy
. JID 1995,171: 1152-8
4) Gao W-Y, Johns DG, Chokekijchai S, Mitsuya H. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2’, 3’-dideoxynucleoside activities against replication of
human immunodeficiency virus
. PANS 1995, 92: 8333-8337
5) Shirasaka T, Chokekijchai S, Yamada A, Gosselin G, Imbach J-L, Mitsuya H. Comparative Analysis of Anti-Human Immunodeficiency Virus Type I Activities of Dideoxynucleoside Analogs
in Resting and Activated Peripheral blood mononuclear cells
. Antimicrob. Agents Chemother.
1995, 39: 2555-2559
6) Chokekijchai S, Shirasaka T, Weinstein JN, Mitsuya H. Invitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or
. Antiviral research 1995, 28: 25-38
7) Chokekijchai S, Kojima E, Anderson S, Nomizu M, Tanaka M, Machida M, Date T, Toyota K, Ishida S, Watanabe K, Yoshioka H, Roller PP, Murakami K, Mitsuya H. NP-06: a Novel Anti-
Human Immunodeficeincy Virus Polypeptide produced by a Streptomyces Species
Antimicrobe. Agents Chemother. 1995, 39:2345-2347.
8) Sorbara LR, Maldarelli F, Chamoun G, Schilling B, Chokekijchai S, Staudt L, Mitsuya H, Simpson IA, Zeichner SL. Human Immunodeficiency Virus Type I Infection of H9 cells Induces Increase
Glucose Transporter Expression
. Journal of Virology 1996, 70:7275-7279



An appointment has been made for your child to have a food challenge. We hope What happens on the day of the challenge? this information will help you to prepare you and your child for the admission. You will be seen by the specialist nurse and doctor. We will complete some paperwork, check your child’s weight and basic observations, explain the procedure and ask you to sign the consent form

CURRICULUM VITAE PERSONAL INFORMATION Lecturer, Department of Biomedical Engineering International University, Vietnam National Uni RESEARCH INTERESTS Controlled bioavailability of poorly water-soluble drugs, solubilization techniques, and development of nano-drug delivery systems. EDUCATION BACKGROUND From 2008 to 2011: Ph.D. Degree in Pharmaceutics , College of Pharmacy, Kangw

Copyright © 2010 Health Drug Pdf